m6A-centered Crosstalk Information
Mechanism of Crosstalk between m6A Modification and Epigenetic Regulation
| Crosstalk ID |
M6ACROT05433
|
[1] | |||
m6A modification
hsa-miR-25-3p
hsa-miR-25-3p
METTL3
Methylation
: m6A sites
Direct
Enhancement
Non-coding RNA
miR-25-3p
PTEN
lncRNA miRNA circRNA
|
|||||
| m6A Modification: | |||||
|---|---|---|---|---|---|
| m6A Regulator | Methyltransferase-like 3 (METTL3) | WRITER | |||
| m6A Target | hsa-miR-25-3p | ||||
| Epigenetic Regulation that have Cross-talk with This m6A Modification: | |||||
| Epigenetic Regulation Type | Non-coding RNA (ncRNA) | ||||
| Epigenetic Regulator | hsa-miR-25-3p | microRNA | View Details | ||
| Regulated Target | Mutated in multiple advanced cancers 1 (PTEN) | View Details | |||
| Crosstalk Relationship | m6A → ncRNA | Enhancement | |||
| Crosstalk Mechanism | m6A regulators directly modulate the functionality of ncRNAs through specific targeting ncRNA | ||||
| Crosstalk Summary | METTL3 involves in the pathogenesis of diabetic retinopathy (DR). Both METTL3 mRNA and hsa-miR-25-3p were low-expressed in the peripheral venous blood samples of diabetes mellitus (DM) patients compared to normal volunteers, and high-glucose inhibited METTL3 and miR-25-3p expressions in RPE cells. Overexpression of METTL3 attenuates high-glucose induced RPE cell pyroptosis by regulating miR-25-3p/Mutated in multiple advanced cancers 1 (PTEN)/Akt signaling cascade through DGCR8. | ||||
| Responsed Disease | Diabetes | ICD-11: 5A10-5A14 | |||
| Pathway Response | PI3K-Akt signaling pathway | hsa04151 | |||
| Cell Process | Cell viability | ||||
| Cell apoptosis | |||||
: m6A sites